WO2010010578A2 - A key intermediate for the preparation of stilbenes - Google Patents
A key intermediate for the preparation of stilbenes Download PDFInfo
- Publication number
- WO2010010578A2 WO2010010578A2 PCT/IN2009/000313 IN2009000313W WO2010010578A2 WO 2010010578 A2 WO2010010578 A2 WO 2010010578A2 IN 2009000313 W IN2009000313 W IN 2009000313W WO 2010010578 A2 WO2010010578 A2 WO 2010010578A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tetrahydropyranyl
- stilbene
- preparation
- pterostilbene
- resveratrol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Definitions
- the present invention relates to the preparation of 3,5-Dimethoxy-4'-O- tetrahydropyranylstilbene, which is a key intermediate for the synthesis of Stilbenes such as Pterostilbene and Resveratrol.
- JMC, 2002, 45 (12), 2534-2542 discloses a process for preparing Pterostilbene by;
- CN 1948274 discloses a process for preparing Pterostilbene by
- CN 1955153 discloses a process for preparing Pterostilbene by; • Condensing 3,5-Dimethoxybenzyl phosphonic acid diethyl esters with hydroxy benzaldehyde methoxymethyl ethers affords the substituted 3, 5-Dimethoxy-4'- methoxymethyloxystyrylbenzene.
- the main object of the present invention is to provide a process to prepare Stilbenes.
- Another object of the present invention is to provide a process for the preparation of Stilbenes by deprotection 3,5-Dialkyl-4'-O-tetrahydropyranylstilbene of formula 1,
- R 1 & R 2 independently represent hydrogen, lower alkyl or aralkyl.
- Another object of the present invention is to provide a process for the preparation of 3,5- Dialkyl-4 ' -O-tetrahydropyranylstilbene .
- Detailed description of the invention is to provide a process for the preparation of 3,5- Dialkyl-4 ' -O-tetrahydropyranylstilbene .
- R 1 & R independently represent hydrogen, lower alkyl or aralkyl.
- Stilbenes are Pterostilbene and Resveratrol.
- Condensation of 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde is carried out in presence of a base, preferably sodium hydride at a temperature ranging from room temperature to reflux temperature of the solvent used.
- a base preferably sodium hydride
- 3,5-Dialkyl-4'-O-tetrahydro pyranylstilbene is carried out in presence of a suitable deprotecting agent selecting from PPTS, aluminum chloride, N,N-dimethylaniline and mixtures thereof.
- a suitable deprotecting agent selecting from PPTS, aluminum chloride, N,N-dimethylaniline and mixtures thereof.
- 3,5-Dialkyl-4'-O- tetrahydropyranylstilbene is found to be novel and it can be a key intermediate for the preparation of Stilbenes, preferably Pterostilbene and Resveratrol.
- 3,5-Dialkyl-4'-O- tetrahydropyranylstilbene is prepared by; • condensing 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4'-O-tetrahydropyranyl Stilbene
- Pterostilbene can be prepared by deprotecting the 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene using pyridinium p-toluene sulfonate (PPTS) in an alcoholic solvent, preferably methanol. The reaction is carried out at room temperature to reflux temperature of the solvent used.
- PPTS pyridinium p-toluene sulfonate
- Resveratrol can be prepared by deprotecting the 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene using Aluminum chloride and N,iV-Dimethylaniline in an organic solvent, preferably toluene. The reaction is carried out at room temperature to reflux temperature of the solvent used. Examples:
- Step-2.2 To a solution of ⁇ -Dimethylaniline (32 g, 0.264 mol) in 500 ml RB flask at RT, was added slowly Aluminum chloride (35.2 g, 0.264 mol) under stirring, over a period of 15 min. The temperature of the reaction rose to 7O 0 C during the addition and toluene (50 ml) was added after 30 min and heated to 8O 0 C for another 30 min. To the reaction mixture at 80 0 C, was added drop wise, 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene (10 g, 0.0294 mol) in toluene (50 ml) under stirring and the contents were heated under reflux for further 3 h.
- Aluminum chloride 35.2 g, 0.264 mol
Abstract
The present invention provides a scalable process for the preparation of Stilbenes by (i) condensing 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4'-O-tetrahydropyranyl Stilbene (ii) deprotecting the obtained 3,5-Dialkyl- 4'-O-tetrahydropyranylstilbene yields Stilbenes. The present invention also provides a novel intermediate 3,5-Dialkyl-4'-O-tetrahydropyranylstilbene, which is a key intermediate for the synthesis of Stilbenes such as Pterostilbene and Resveratrol.
Description
"A key intermediate for the preparation of Stilbenes"
Field of the invention:
The present invention relates to the preparation of 3,5-Dimethoxy-4'-O- tetrahydropyranylstilbene, which is a key intermediate for the synthesis of Stilbenes such as Pterostilbene and Resveratrol.
Background of the invention:
Methods for preparing Stilbenes such as Pterostilbene and Resveratrol are known in the art. JMC, 2002, 45 (12), 2534-2542 discloses a process for preparing Pterostilbene by;
• Condensing 3,5-Dύnethoxybenzyltriphenylphosphonium bromide with 4-(tert- butyldimethylsilyloxy) benzaldehyde in tetrahydrofuran yields 4'-(tert- butyldimethyl silyloxy)-3,5-dimethoxystilbene. • Treating 4'-(tert-Butyldimethylsilyloxy)-3,5-dimethoxystilbene with tetrabutyl ammonium fluoride affords Pterostilbene
CN 1948274 discloses a process for preparing Pterostilbene by;
• Condensing 4-benzyloxybenzaldehyde with 3,5-dimethoxybenzyl phosphonate in presence of sodium hydride yields 3,5-dimethoxy-4'-benzyloxystilbene and
• Debenzylating 3,5-dimethoxy-4'-benzyloxystilbene with aluminum chloride and iVJV-dimethylaniline in dichloromethane yields Pterostilbene.
CN 1955153 discloses a process for preparing Pterostilbene by; • Condensing 3,5-Dimethoxybenzyl phosphonic acid diethyl esters with hydroxy benzaldehyde methoxymethyl ethers affords the substituted 3, 5-Dimethoxy-4'- methoxymethyloxystyrylbenzene.
• Treating 3, 5-Dimethoxy-4'- methoxymethyloxystyrylbenzene dissolved in methanol with Pyridiniump-toluene sulfonate (PPTS) yields Pterostilbene.
Indian Journal of Chemistry, Section B: 2002, 41B (11), 2395-2398 discloses a process for preparing Resveratrol by;
• Treating Tri-O-methyl(-OMe) or tri-0-benzyl (-OCH2Ph) Resveratrol with BBr3 in CH2Cl2 yields Resveratrol.
US 7,253,324 discloses a process for preparing Resveratrol by;
• Treating Tri-O-methyl(-OMe) or tri-O-benzyl (-OCH2Ph) Resveratrol with AICI3/N, iV-dimethylaniline yields Resveratrol. The limitations of the above methods are scalability and difficulty in selective deprotection to prepare Pterostilbene and use of expensive reagents for protection and/or low yields obtained in the process. So there is a need of the industry to have a process that is scalable and without using expensive reagents.
According to the present invention there is provided a convenient process for the preparation of Stilbene with desired purity and yield by using a novel intermediate 3 ,5-Dialkyl-4 ' -0-tetrahydropyranylstilbene.
Summary of the invention:
The main object of the present invention is to provide a process to prepare Stilbenes.
Another object of the present invention is to provide a process for the preparation of Stilbenes by deprotection 3,5-Dialkyl-4'-O-tetrahydropyranylstilbene of formula 1,
Wherein R1 & R2 independently represent hydrogen, lower alkyl or aralkyl.
Another object of the present invention is to provide a process for the preparation of 3,5- Dialkyl-4 ' -O-tetrahydropyranylstilbene . Detailed description of the invention:
Thus in accordance with the present invention preparation of Stilbenes comprising the steps of:
• condensing 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde to get 3,5-dialkyl-4'-O-tetrahydropyranyl Stilbene • deprotecting the obtained 3,5-Dialkyl-4'-O-tetrahydropyranylstilbene yields
Stilbene
The reaction steps are illustrated in scheme- 1.
Scheme 1
Wherein R1 & R independently represent hydrogen, lower alkyl or aralkyl.
The process as described above wherein the preferable Stilbenes are Pterostilbene and Resveratrol.
Condensation of 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde is carried out in presence of a base, preferably sodium hydride at a temperature ranging from room temperature to reflux temperature of the solvent used.
Deprotection of the above obtained compound i.e. 3,5-Dialkyl-4'-O-tetrahydro pyranylstilbene is carried out in presence of a suitable deprotecting agent selecting from PPTS, aluminum chloride, N,N-dimethylaniline and mixtures thereof. In a specific embodiment of the present invention 3,5-Dialkyl-4'-O- tetrahydropyranylstilbene is found to be novel and it can be a key intermediate for the preparation of Stilbenes, preferably Pterostilbene and Resveratrol.
In another embodiment of the present invention 3,5-Dialkyl-4'-O- tetrahydropyranylstilbene is prepared by; • condensing 3,5-dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4'-O-tetrahydropyranyl Stilbene
The process as described above wherein the condensation is carried in presence of a base, wherein the preferred base is sodium hydride. And the reaction is carried out in a solvent preferably tetrahydrofuran. In another embodiment of the present invention Pterostilbene can be prepared by deprotecting the 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene using pyridinium p-toluene sulfonate (PPTS) in an alcoholic solvent, preferably methanol. The reaction is carried out at room temperature to reflux temperature of the solvent used.
In another embodiment of the present invention Resveratrol can be prepared by deprotecting the 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene using Aluminum chloride and N,iV-Dimethylaniline in an organic solvent, preferably toluene. The reaction is carried out at room temperature to reflux temperature of the solvent used. Examples:
The present invention will now be further explained in the following examples. However, the present invention should not be construed as limited thereby. One of ordinary skill in the art will understand how to vary the exemplified preparations to obtain the desired results. Example-1: Synthesis of Pterostilbene:
Step-1.1:
To the sodium hydride (1.66 g, 0.0694 mol) suspension in tetrahydrofuran (40 ml) at O0C was added diethyl-3,5-dimethoxy benzyl phosphonate (10 g, 0.0347 mol) and resulting dark solution was stirred under nitrogen at room temperature for 30 min. A solution of 4'-O-tetrahydropyranyl benzaldehyde (7.84 g, 0.0381 mol) , in tetrahydrofuran (20 ml) was added at 18-2O0C and the mixture stirred at room temperature for about 2-3 hours. After completing the reaction added methanol (10 ml) drop wise at 0-50C, resulting solution was poured into ice-water and extracted with ethyl acetate (50 ml). Organic layer washed with water (10 ml) and dried over sodium sulfate and removed ethyl acetate under reduced pressure at 4O0C to obtain semi solid and which on treating with methanol given pure solid compound (8.2 g, purity by HPLC 98.4%).
Step-1.2:
To a solution of 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene (10 g, 0.0294 mol) in methanol (50 ml) at RT was added PPTS (0.369 g, 0.264 mol) under stirring and contents were heated under reflux for 1 h. After completion of the reaction, solvent was distilled off under reduced pressure to get residue. The residue was dissolved in ethyl acetate and treated with 5% HCl, then with 5% NaHCθ3, finally with water and separated organic phase. Removal of solvent in vacuo from the organic phase yielded the crude Pterostilbene, which was purified further by washing with 10% ethyl acetate and hexanes (10 ml) to get pure Pterostilbene (5.5- 6.7 g, purity by HPLC 99%).
Example-2: Synthesis of Resveratrol: Step-2.1:
To the sodium hydride (1.66 g, 0.0694 mol) suspension in tetrahydrofuran (40 ml) at O0C was added diethyl-3,5-dimethoxy benzyl phosphonate (10 g, 0.0347 mol) and
resulting dark solution was stirred under nitrogen at room temperature for 30 min. A solution of 4'-O-tetrahydropyranyl benzaldehyde (7.84 g, 0.0381 mol) in tetrahydrofuran (20 ml) was added at 18-2O0C and the mixture stirred at room temperature for about 2-3 hours. After completing the reaction added methanol (10 ml) drop wise at 0-50C, resulting solution was poured into ice-water and extracted with ethyl acetate (50 ml). Organic layer washed with water (10 ml) and dried over sodium sulfate and removed ethyl acetate under reduced pressure at 4O0C to obtain semi solid and which on treating with methanol given pure solid compound ( 8.2 g, purity by HPLC 98.4%).
Step-2.2: To a solution of Λ^-Dimethylaniline (32 g, 0.264 mol) in 500 ml RB flask at RT, was added slowly Aluminum chloride (35.2 g, 0.264 mol) under stirring, over a period of 15 min. The temperature of the reaction rose to 7O0C during the addition and toluene (50 ml) was added after 30 min and heated to 8O0C for another 30 min. To the reaction mixture at 800C, was added drop wise, 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene (10 g, 0.0294 mol) in toluene (50 ml) under stirring and the contents were heated under reflux for further 3 h. After completion of the reaction, the contents were cooled to room temperature and the solvent was decanted. The residue was treated with dil.HCl (30 ml) and extracted the product into ethyl acetate (2 x 50 ml), solvent was distilled off under reduced pressure to obtain crude Resveratrol which was purified further by washing with dichloromethane (10 ml) to get pure Resveratrol (4.7- 6.0 gm, purity by HPLC 99%).
Claims
1. A compound of the formula 1
2. A process for the preparation of compound of the formula 1, by condensing 3,5- Dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde in presence of a base.
3. The process as claimed in claim 2, wherein the preferable base is sodium hydride 4. A process for the preparation of Stilbene of general formula 2,
Wherein R1 & R2 independently represent hydrogen, lower alkyl or aralkyl, Comprising the steps of;
• condensing Dialkylbenzyl phosphonates with 4'-O-tetrahydropyranyl benzaldehyde to get 3,5-alkyl-4'-O-tetrahydropyranyl Stilbene
• deprotecting the obtained 3,
5-Dialkyl-4'-O-tetrahydropyranylstilbene yields Stilbene 5. The process as claimed in claim 4, wherein the Stilbene is Pterostilbene.
6. The process as claimed in claim 4, wherein the Stilbene is Resveratrol.
7. A process for the preparation of Pterostilbene comprising the steps of;
• condensing 3,5-dimethoxybenzyl phosphonic acid diethyl ester with 4'-O- tetrahydropyranyl benzaldehyde to get 3,5-dimethoxy-4'-O- tetrahydropyranyl Stilbene • deprotecting the obtained 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene yields Pterostilbene
8. The process as claimed in claim 7, wherein the deprotection is carried out using Pyridinium p-toluene sulphonate.
9. A process for the preparation of Resveratrol, comprising the steps of; • condensing 3,5-dimethoxybenzyl phosphonic acid diethyl ester with 4'-O- tetrahydropyranyl benzaldehyde to get 3,5-dimethoxy-4'-O- tetrahydropyranyl Stilbene
• deprotecting the obtained 3,5-Dimethoxy-4'-O-tetrahydropyranylstilbene yields Resveratrol 10. The process as claimed in claim 9, wherein the deprotection is carried out using
Aluminum chloride and N,N- dimethylaniline.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2010/022285 WO2010141107A1 (en) | 2009-06-01 | 2010-01-27 | Solid forms of pterostilbene |
US13/011,593 US8524782B2 (en) | 2008-07-23 | 2011-01-21 | Key intermediate for the preparation of Stilbenes, solid forms of Pterostilbene, and methods for making the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1766/CHE/2008 | 2008-07-23 | ||
IN1766CH2008 | 2008-07-23 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/022285 Continuation-In-Part WO2010141107A1 (en) | 2008-07-23 | 2010-01-27 | Solid forms of pterostilbene |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/011,593 Continuation-In-Part US8524782B2 (en) | 2008-07-23 | 2011-01-21 | Key intermediate for the preparation of Stilbenes, solid forms of Pterostilbene, and methods for making the same |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010010578A2 true WO2010010578A2 (en) | 2010-01-28 |
WO2010010578A3 WO2010010578A3 (en) | 2010-11-11 |
Family
ID=41570679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2009/000313 WO2010010578A2 (en) | 2008-07-23 | 2009-06-01 | A key intermediate for the preparation of stilbenes |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010010578A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103102254A (en) * | 2013-02-06 | 2013-05-15 | 浙江新赛科药业有限公司 | Pterostilbene synthesis method |
CN103450130A (en) * | 2013-09-13 | 2013-12-18 | 陕西嘉禾植物化工有限责任公司 | Toluylene compound and preparation method thereof |
CN103467255A (en) * | 2013-09-13 | 2013-12-25 | 陕西嘉禾植物化工有限责任公司 | Synthetic method of natural product pterostilbene |
CN114929659A (en) * | 2019-12-20 | 2022-08-19 | 晶体工程智能研究中心公司 | Co-crystals of pterostilbene and compositions comprising them |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1948274A (en) * | 2006-10-25 | 2007-04-18 | 沈阳药科大学 | Verakanol derivative, its preparation method and use |
CN1955153A (en) * | 2005-10-24 | 2007-05-02 | 南京莱因医药科技有限公司 | Synthetic method of pterostilbene |
-
2009
- 2009-06-01 WO PCT/IN2009/000313 patent/WO2010010578A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1955153A (en) * | 2005-10-24 | 2007-05-02 | 南京莱因医药科技有限公司 | Synthetic method of pterostilbene |
CN1948274A (en) * | 2006-10-25 | 2007-04-18 | 沈阳药科大学 | Verakanol derivative, its preparation method and use |
Non-Patent Citations (1)
Title |
---|
YUE-QING, LI ET AL.: 'Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication' pages 1085 - 1086 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103102254A (en) * | 2013-02-06 | 2013-05-15 | 浙江新赛科药业有限公司 | Pterostilbene synthesis method |
CN103102254B (en) * | 2013-02-06 | 2015-08-26 | 浙江新赛科药业有限公司 | The synthetic method of a kind of Pterostilene |
CN103450130A (en) * | 2013-09-13 | 2013-12-18 | 陕西嘉禾植物化工有限责任公司 | Toluylene compound and preparation method thereof |
CN103467255A (en) * | 2013-09-13 | 2013-12-25 | 陕西嘉禾植物化工有限责任公司 | Synthetic method of natural product pterostilbene |
CN114929659A (en) * | 2019-12-20 | 2022-08-19 | 晶体工程智能研究中心公司 | Co-crystals of pterostilbene and compositions comprising them |
Also Published As
Publication number | Publication date |
---|---|
WO2010010578A3 (en) | 2010-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9604914B2 (en) | Process for preparing N-(4-cyclohexyl-3-trifluoromethyl-benzyloxy)-acetimidic acid ethyl ester | |
US8101804B2 (en) | Process for the synthesis of (E)-stilbene derivatives which makes it possible to obtain resveratrol and piceatannol | |
SG187565A1 (en) | Process for preparing benzofuran derivatives substituted at position 5 | |
Chae | Practical demethylation of aryl methyl ethers using an odorless thiol reagent | |
WO2010010578A2 (en) | A key intermediate for the preparation of stilbenes | |
US20150321983A1 (en) | A process for the preparation of ospemifene | |
JP2006225391A (en) | Preparation procedure of tolterodine | |
KR101308258B1 (en) | A novel method of making Endoxifen | |
CN109053525B (en) | Preparation method of (R) -2- (2-substituted-5-fluorobenzene) pyrrolidine | |
CN113105357B (en) | Synthesis method and application of novel p-aryl azophenol derivative | |
JP2008546818A (en) | Process for producing 1- [cyano (4-hydroxyphenyl) methyl] cyclohexanol compound | |
WO2006062477A1 (en) | Chemical process | |
HU187796B (en) | Process for producing 1-bracket-3-benzyloxy-phenyl-bracker closed-1,1-dimethyl-heptane | |
AU2001287702B2 (en) | Intermediates for use in the preparation of vitamin E | |
WO2006109570A1 (en) | Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate | |
JP4157361B2 (en) | Method for producing 9-spirofluorene compound | |
JP2003104926A (en) | Method for producing alkyl ether of hydroquinones | |
CN113292401B (en) | Preparation method of higher fatty alcohol 2-alkoxyl ethanol | |
CN103183591B (en) | 4 '-dialkoxymethyl bis cyclohexane-4-base methyl alcohol and manufacture method thereof | |
KR101321702B1 (en) | Novel method for preparing 3-[5'-(3,4-bis-hydroxymethyl-benzyloxy)-2'-ethyl-2-propyl-biphenyl-4-yl]-pentan-3-ol | |
AU2001287702A1 (en) | Intermediates for use in the preparation of vitamin E | |
WO2002090305A1 (en) | A new method for the preparation of 2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]ethoxy}ethanol and its isomers | |
JP4188060B2 (en) | Method for producing 1-substituted phenyl-ω-bromoalkane | |
KR100390026B1 (en) | Preparation method of n-methyl-3-£(4-trifluoromethyl)phenoxy| -3-phenylpropylamine | |
JP2003104928A (en) | Method for producing hydroxyacetophenones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09800157 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09800157 Country of ref document: EP Kind code of ref document: A2 |